A combination therapy with mitomycin c, etoposide, doxifluridine and medroxyprogesterone acetate as second line therapy for advanced breast cancer refractory to combination chemotherapy of cyclophosphamide, doxorubicin and 5 fluorouracil-Reference-Cited by-同舟云学术

A combination therapy with mitomycin c, etoposide, doxifluridine and medroxyprogesterone acetate as second line therapy for advanced breast cancer refractory to combination chemotherapy of cyclophosphamide, doxorubicin and 5 fluorouracil

Published:1997-07 Issue:2 Volume:4 Page:115-119
ISSN:1340-6868
Container-title:Breast Cancer
language:en
Short-container-title:Breast Cancer

Author:

Kuroi Katsumasa,Osaki Akihiko,Kawami Hiroyuki,Murakami Shigeru,Toge Tetsuya

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF02967064.pdf

Reference24 articles.

1. Tranum B, Hoogstraten B, Kennedy A,et al: Adriamycin in combination for the treatment of breast cancer.Cancer 41:2078–2083, 1978.

2. Tormey DC, Weinberg VE, Leone LA,et al: A comparison of intermittent vs continuous and of adriamycin vs methotrexate 5-drug chemotherapy for advanced breast cancer.Am J Clin Oncol 7:231–239, 1984.

3. Yoshinaka K, Yagi M, Ohtagaki S,et al: 5’-deoxy- fluorouridine (5’DFUR), mitomycin C (MMC), etoposide and medroxyprogesterone acetate (MPA) in a previously treated patient with advanced breast cancer.Jpn J Cancer Chemother 18:115–118, 1991 (in Japanese with English summary).

4. Japanese Breast Cancer Society: General Rules for Clinical and Pathological Recording of Breast Cancer, 11th ed, Kanehara, Tokyo, pp1–61, 1992.

5. van Oosterom AT, Powles TJ, Hamersma E,et al: A phase II study of mitomycin C in refractory advanced breast cancer; A multi-centre pilot study. In: Mouridsen HT, Palshof T eds, Breast Cancer; Experimental and Clinical Aspects, Pergamon Press, Elmsfold, pp275–276, 1980.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alkylating Agents;Cancer Management in Man: Chemotherapy, Biological Therapy, Hyperthermia and Supporting Measures;2010-11-03